Press Releases
-
24 Mar, 2026Spago Nanomedical’s abstract on Tumorad® accepted for presentation at radiopharma conference
-
17 Mar, 2026Spago Nanomedical continues recruitment in the phase I/IIa Tumorad-01 study following positive DMC recommendation
-
10 Mar, 2026Spago Nanomedical strengthens CMC and supply capabilities to support next phase of Tumorad development
-
5 Feb, 2026Spago Nanomedical year-end report January-December, 2025
-
8 Dec, 2025Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2026